Sonic Hedgehog Signaling in Inner Ear Organoid Development
内耳类器官发育中的 Sonic Hedgehog 信号传导
基本信息
- 批准号:9336149
- 负责人:
- 金额:$ 2.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2019-08-31
- 项目状态:已结题
- 来源:
- 关键词:AgingAgonistAreaAuditoryBiochemicalBiological ModelsCell TherapyCell modelCellsCellular biologyCochleaDNA Sequence AlterationDerivation procedureDevelopmentDimensionsDiseaseDorsalES Cell LineElectrophysiology (science)ExhibitsFBXO2 geneFoundationsFunctional disorderGenerationsGravity PerceptionHair CellsHearingHumanImmunohistochemistryIn VitroInheritedLaboratoriesLabyrinthLoudnessMethodsModelingMolecular BiologyMorphogenesisMorphologyMusNatural regenerationNatureNoiseOrganOrgan of CortiOrganoidsOtic VesiclePathologyPatternPharmaceutical PreparationsPlayPluripotent Stem CellsPopulationPreclinical Drug EvaluationProcessPropertyQuantitative Reverse Transcriptase PCRReporterResearchRoleSHH geneSensorineural Hearing LossSensorySensory HairSensory ReceptorsSignal TransductionSonic Hedgehog PathwayStem cellsStructureStudy modelsSystemTestingTissuesType II Hair CellVestibular Hair Cellscell typedeafnessembryonic stem cellhuman pluripotent stem cellhuman tissuein uteroinner ear developmentinner ear diseasesnovelototoxicityprogenitorpurmorphaminesmall moleculesmoothened signaling pathwaysoundthree dimensional cell culture
项目摘要
ABSTRACT
Loss of the finite cochlear hair cells in the inner ear results in sensorineural deafness. Human
cochlear hair cells do not regenerate, and there is no cure for deafness. Our lab has recently
established a novel three-dimensional culture system for deriving functional sensory hair cells from
mouse and human pluripotent stem cells. A major limitation of this approach, however, is that derived
hair cells exhibit structural, biochemical and electrophysiological properties of gravity-sensing
vestibular hair cells. The processes underlying the commitment to cochlear versus vestibular fate in
inner ear sensory hair cell development are poorly understood. Previous studies have shown that
establishment of a dorsal-ventral (DV) axis in the developing otic vesicle is necessary for proper
morphogenesis of both auditory and vestibular inner ear structures. Sonic hedgehog signaling has
been shown to play a key role in precise DV patterning of the otic vesicle. In Specific Aim 1, I will
characterize the nature of DV patterning in otic vesicles derived using our three-dimensional inner ear
culture model, and determine whether commitment to a vestibular fate is due to a lack of ventralizing
signals. In Specific Aim 2, I will assess whether modulation of Sonic hedgehog signaling via small
molecule application in our culture model is able to induce differentiation of cochlear cell types. Stem
cell-derived cochlear hair cells may serve as a potent human model system to study pathophysiology
of various forms of hereditary deafness. Such an advance could profoundly impact our understanding
of disease processes that normally occur in utero. Furthermore, an in vitro system recapitulating both
cochlear and vestibular sensory cell development is amenable to high-throughput drug screening to
identify compounds that either enhance inner ear differentiation, promote the survival of inner ear
sensory cells, or have ototoxic effects.
摘要
内耳中有限耳蜗毛细胞的丧失导致感音神经性耳聋。人类
耳蜗毛细胞不能再生,耳聋也无法治愈。我们的实验室最近
建立了一种新的三维培养系统,用于从
小鼠和人类多能干细胞。然而,这种方法的一个主要限制是,
毛细胞具有重力感应的结构、生物化学和电生理特性
前庭毛细胞耳蜗与前庭命运的潜在承诺过程
内耳感觉毛细胞的发育知之甚少。以前的研究已经表明
在发育中的耳泡中建立背腹(DV)轴对于正确的
听觉和前庭内耳结构的形态发生。音速刺猬信号
已显示在耳泡的精确DV图案化中起关键作用。在具体目标1中,我将
表征使用我们的三维内耳导出的耳泡中DV图案的性质
文化模式,并确定是否承诺前庭的命运是由于缺乏腹
信号.在具体目标2中,我将评估是否通过小的
在我们的培养模型中应用分子能够诱导耳蜗细胞类型的分化。干
细胞来源的耳蜗毛细胞可以作为一个有效的人类模型系统,以研究病理生理学
各种遗传性耳聋这样的进步可能会深刻地影响我们对
通常在子宫内发生的疾病过程此外,一个体外系统概括了两者,
耳蜗和前庭感觉细胞的发育适合于高通量药物筛选,
鉴定增强内耳分化、促进内耳存活的化合物
感觉细胞,或具有耳毒性作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Emma Longworth-Mills其他文献
Emma Longworth-Mills的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 2.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 2.83万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 2.83万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 2.83万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 2.83万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 2.83万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 2.83万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 2.83万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 2.83万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 2.83万 - 项目类别:














{{item.name}}会员




